Tagcyx Biotechnologies
1 known investors
Tagcyx Biotechnologies is a Japanese drug-discovery company developing therapeutics based on artificial nucleic acid aptamers (Xenologo/DNA aptamers using the artificial base Ds), targeting conditions such as Hunner-type interstitial cystitis, preeclampsia, and infectious and ophthalmic diseases. It runs research programs and collaborations with universities and pharmaceutical companies to identify aptamer drug candidates.
Founders & leadership
CK
Chizuko Koseki
Investors · 1
Frequently asked questions
- What does Tagcyx Biotechnologies do?
- Tagcyx Biotechnologies is a Japanese drug-discovery company developing therapeutics based on artificial nucleic acid aptamers (Xenologo/DNA aptamers using the artificial base Ds), targeting conditions such as Hunner-type interstitial cystitis, preeclampsia, and infectious and ophthalmic diseases. It runs research programs and collaborations with universities and pharmaceutical companies to identify aptamer drug candidates.
- Who are Tagcyx Biotechnologies's investors?
- Tagcyx Biotechnologies's investors include UTokyo Innovation Platform Co. Ltd..